Herbas VPB

Print
EN | LT
LT - N-(5-tret-butil-izoksazol-3-il)-N`-{4-[7-(2-morfolin-4-il-metoksi-)imidazo-[2,1-B]-[1,3]- benzotiazol-2-il]-fenil}karbamido skyrimo būdai, skirti proliferacinės ligos gydymui
EN - METHODS OF ADMINISTERING N-(5-TERT-BUTYL-ISOXAZOL-3-YL)-N`-{4-[7-(2-MORPHOLIN-4-YL-ETHOXY-)IMIDAZO-[2,1-B]-[1,3]-BENZOTHIAZOL-2-YL]-PHENYL}UREA TO TREAT PROLIFERATIVE DISEASE

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/5377 (2006.01)
A61P 35/00 (2006.01)
A61P 35/02 (2006.01)
European patent
(11) Number of the document 2205244
(13) Kind of document T
(96) European patent application number 08847113.1
Date of filing the European patent application 2008-11-07
(97) Date of publication of the European application 2010-07-14
(45) Date of publication and mention of the grant of the patent 2013-08-21
(46) Date of publication of the claims translation 2014-01-27
PCT application
(86) Number PCT/US2008/012539
Date 2008-11-07
PCT application publication
(87) Number WO 2009/061446
Date 2009-05-14
Priority applications
(30) Number Date Country code
2583 P 2007-11-08 US
5803 P 2007-12-07 US
98676 P 2008-09-19 US
112060 P 2008-11-06 US
Inventors
(72)
JAMES, Joyce, K., US
EICHELBERGER, Shawn R., US
SAVALL, Traci L., US
Grantee
(73) Ambit Biosciences Corporation, 11080 Roselle Street San Diego, CA 92121, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) N-(5-tret-butil-izoksazol-3-il)-N`-{4-[7-(2-morfolin-4-il-metoksi-)imidazo-[2,1-B]-[1,3]- benzotiazol-2-il]-fenil}karbamido skyrimo būdai, skirti proliferacinės ligos gydymui
  METHODS OF ADMINISTERING N-(5-TERT-BUTYL-ISOXAZOL-3-YL)-N`-{4-[7-(2-MORPHOLIN-4-YL-ETHOXY-)IMIDAZO-[2,1-B]-[1,3]-BENZOTHIAZOL-2-YL]-PHENYL}UREA TO TREAT PROLIFERATIVE DISEASE
Last renewal fee
Payment date Validity (years) Amount
2024-10-04 17 347.00 EUR
Next renewal fee
2025-11-07